The FDA’s guidance on AI in drug development points to potentially life-threatening consequences of the technology, highlighting the importance of providing the regulator with detailed information ...

The FDA has granted Cour Pharmaceuticals orphan drug designation for CNP-104, a biodegradable nanoparticle in development for ...

Duxin Sun receives funding from the NIH, FDA, and pharmaceutical industries ... AI and machine learning to every stage of the drug development process. This includes identifying targets in the ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

an expedited FDA process tailored to new treatments for serious or life-threatening diseases. Landgren said the result will be streamlined drug development, clinical testing and regulatory review ...

Gelteq Limited, a biotechnology company focused on gel-based delivery solutions, announced that the FDA has approved its suitability petition for a new animal drug under development. This ...

Reforming patent litigation to mirror successful outcomes across Europe could significantly accelerate US biosimilar market ...

The FDA published its first draft guidance on the use of AI in the development of drugs and biological products ...

FDA introduces guidelines for lead levels in processed baby foods, aiming to enhance infant safety and reduce exposure to ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...